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Polymorphisms in cytokine genes can alter the production of these proteins and consequently affect the immune response. The
trihybrid heterogeneity of the Brazilian population is characterized as a condition for the use of ancestry informative markers.The
objective of this study was to evaluate the frequency of -1031T>C, -308G>A and -238G>A TNFA, +874 A>T IFNG and -819C>T,
and -592C>A IL10 gene polymorphisms and their association with malaria vivax and genomic ancestry. Samples from 90 vivax
malaria-infected individuals and 51 noninfected individuals from northern Brazil were evaluated. Genotyping was carried out by
using ASO-PCR or PCR/RFLP. The genomic ancestry of the individuals was classified using 48 insertion/deletion polymorphism
biallelic markers. There were no differences in the proportions of African, European, and Native American ancestry between men
andwomen. No significant associationwas observed for the allele and genotype frequencies of the 6 SNPs betweenmalaria-infected
and noninfected individuals. However, there was a trend toward decreasing the frequency of individuals carrying the TNF-308A
allele with the increasing proportion of European ancestry. No ethnic-specific SNPs were identified, and there was no allelic or
genotype association with susceptibility or resistance to vivaxmalaria. Understanding the genomic mechanisms by which ancestry
influences this association is critical and requires further study.
1. Introduction
With the completion of the Human Genome Project and
the ease of identifying variations in DNA using currently
available tools, several studies on genetic associations have
evaluated the genetic bases of certain traits (e.g., the suscepti-
bility to clinical manifestations of various types of diseases,
including diabetes, cancer, and hypertension, as well as
autoimmune, infectious parasitic, and cardiac diseases) [1–6].
Thus, based on the genetic variability, these association stud-
ies are based on comparisons of the allele and/or genotype
frequencies of some SNPs present in candidate genes between
a group who have the disease or the outcome of interest and
an unaffected group [7, 8].
Malaria is one of the most studied infectious diseases. It is
the primary parasitic disease worldwide and is responsible for
approximately 214 million cases annually, resulting in more
than 438,000 deaths [9]. Currently, it is widely accepted that
genetic factors of the human host contribute to the infection
and different clinical manifestations of the disease [10–12].
Theobserved genetic variants associatedwithmalaria include
those present in erythrocytes, which play an essential role as
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host cells during the asexual life cycle of the parasite [13–
15]. Moreover, polymorphisms in cytokine genes can alter
the production or activity of these proteins and consequently
affect the inflammatory response to malaria [16–18]. As a
result, these polymorphisms may be associated with suscep-
tibility to or progression of disease [17, 19].
The prognosis of Plasmodium infection depends on the
balance between pro- and anti-inflammatory cytokines [20–
23]. IFN-𝛾, TNF-𝛼, IL-6, IL-12, IL-1𝛽, and IL-8 are reported
at higher levels in individuals infected with Plasmodium than
in controls or in individuals with severe malaria [21, 24, 25].
However, contradictory results have also been observed, with
lower levels of these cytokines reported in infected patients
[25, 26].
TNF-𝛼 participates in tumorigenesis, apoptosis, immune
cell activation, hyperthermia [18, 22], and parasitemia reduc-
tion [27, 28]. However, it can play different, concentration-
dependent roles in malaria, ranging from protection against
the destructive activity of infection on the vascular and brain
endothelium to changes in blood glucose levels [29, 30].
SNPs in this gene have the potential to alter transcription
factors, influencing the circulating levels of the cytokine [16].
The A (-308) and C (-1031) alleles have been associated with
circulating levels of the cytokine and with clinical symptoms
but not with susceptibility [27], whereas the G allele (-308)
has been associated with increased susceptibility to malaria
vivax [19]. Other alleles at positions -1031T, -863C, -857T,
-308G, and -238G have been associated with an increased
risk of developing cerebral malaria in patients in Myanmar
[31].
IFN-𝛾 acts as a regulator of antigen presentation, prolif-
eration, and differentiation in lymphocyte populations and
plays a modulatory role in the immune response mediated by
anti-inflammatory cytokines [32], such as IL-10. In malaria,
this cytokine is believed to play roles in both pathogenesis
and protection [33]. Some studies have evaluated potential
associations between IFNG gene polymorphisms (including
SNP +874A>T) and malaria and found no association with
susceptibility to vivaxmalaria [17] or severity of P. falciparum
infections [34]. A recent study also found no association
between the presence of SNP +874A>T and the antibody
response against P. vivax blood-stage proteins [35]. However,
in Brazil, individuals infected with P. vivax carrying the AA
genotype showed lower levels of IFN-𝛾 [21].
IL-10 cytokine has a negative immunoregulatory effect
[36, 37] on IL-1, IL-6, IL-8, IL-12, IFN-𝛾, and TNF-𝛼 [17, 27]
that is essential for maintaining homeostasis and limiting
tissue damage by infectious agents [34]. The production of
the IgG, IgA, and IgM isotypes induced by IL-4 is synergistic
with IL-10 [38]. However, high levels can contribute to the
maintenance of the parasite in the host and can be related
to cerebral malaria and high levels of parasitemia [20, 21,
24]. The proportion of C alleles of SNPs -819 and -592 was
lower in individuals infected with P. vivax than in healthy
individuals. Furthermore, individuals carrying the genotypes
-819CC and -592CC had lower levels of circulating IL-10
[17]. By contrast, another study conducted in the Brazilian
Amazon found no association between the presence of these
SNPs and susceptibility to P. vivax [21].
Thus, certain aspects of these observed associations have
proven irreproducible in subsequent studies performed in
different populations [39–41], with contradictory results for
different SNP associations with susceptibility to different
Plasmodium species and levels of circulating cytokines and
antibodies.There aremany reasons for the lack of consistency
in these results, but discrepancies are often due to popu-
lation stratification, which can occur in populations with
different allele frequencies between and within subgroups
[8]. If the population subgroups are represented in different
proportions between individuals of the case and control
groups, then spurious associations may be observed; thus,
ancestry informative markers (AIMs) have been employed
in an attempt to avoid the population stratification problem
[42, 43].
This consideration is particularly important in studies
involving admixed populations, as is the case in the Brazilian
population due to crosses involving primarily Europeans,
Africans, and Native Americans. Previous studies employing
AIMs in Brazil demonstrated that the allele distributions
in genes involved in pharmacokinetics [44, 45] or in the
costimulation of B and T lymphocytes [46] were affected
by the proportions of genetic ancestry. The frequencies of
several cytokine gene alleles vary significantly among some
ethnic groups and geographic populations. Moreover, the
lack of data on Native Americans in the Brazilian population
motivated us to investigate the frequency of polymorphisms
in TNFA, INFG, and IL10 genes in people living in a malaria-
endemic area of the Brazilian Amazon and their possible
association with malaria vivax and genomic ancestry.
2. Materials and Methods
2.1. Sample. The sample used in this study was from the
municipality of Goiane´sia do Para´, Para´ state (03∘50󸀠33󸀠󸀠S;
49∘05󸀠49󸀠󸀠W), Brazil, which is a malaria-endemic area in the
Brazilian Amazon.The sample was a subset of the individuals
analyzed in Cassiano et al. [46]. A total of 141 unrelated
individuals older than 14 yearswere recruited at theGoiane´sia
do Para´ Malaria Diagnosis Center. Of these individuals,
90 were diagnosed with vivax malaria by microscopy, and
infection was subsequently confirmed using nested-PCR; no
infections by any human malaria species were observed in
the remaining 51 individuals. All participants or guardians
signed the consent form, and the project was approved
by the Goiane´sia do Para´ health authorities and by the
Research Ethics Committee (CAAE 01774812.2.0000.5415) of
the College of Medicine of Sa˜o Jose´ do Rio Preto (Faculdade
de Medicina de Sa˜o Jose´ do Rio Preto).
2.2. DNA Extraction and Genotyping. DNA was extracted
using an Easy-DNA extraction/purification kit (Invitrogen,
CA, USA), according to the manufacturer’s specifications.
2.2.1. TNFA Genotyping. Three different SNPs [-238G>A
(rs361525), -308G>A (rs1800629), and -1031T>C
(rs1799964)] were genotyped within the promoter region of
TNFA gene through PCR-RFLP method according to the
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following conditions and primers. For the -308G>A position
(rs1800629), were used the oligonucleotides forward 5󸀠-GAG
GCA ATA GGT TTT GAG GGC CAT-3󸀠 and reverse
5󸀠-GGG ACA CAC AAG CAT CAAG-3󸀠. A quantity of
100 ng of DNAwas used with 1x buffer (20mMTris-HCl [pH
8.4], 500mM KCl), 5% of glycerol, 1.5mM MgCl2, 0.2𝜇M
of each dNTP, 0.6 pmol of each primer, and 0.5U of Taq
Platinum DNA Polymerase (Invitrogen, Sa˜o Paulo, Brazil).
The amplification process consisted of an initial denaturation
step of 94∘C for 5min and 35 denaturing cycles (94∘C for
30 s, 59∘C for 30 s, and 72∘C for 1min), which was followed
by a final extension at 72∘C for 5min.The PCR products were
visualized on a 2% agarose gel stained with 2.5% GelRed
(Biotium, Hayward, USA). The PCR products at 147 bp
were digested with NcoI (Fermentas, Vilnius, Lithuania)
restriction endonuclease for 3 hours at 37∘C to identify the
genotypes [47]. The digestion products were stained with
2.5% GelRed (Biotium, Hayward, USA) and viewed on a
12.5% polyacrylamide gel after ethidium bromide staining.
The resulting fragment for the AA genotype was 147 bp, while
the fragments for the GG genotypes were 126 and 21 bp, and
those for the GA genotypes were 147, 126, and 21 bp [47].
The following oligonucleotides were used for the TNFA-
1031T>C SNP (rs1799964): forward 5󸀠-TAT GTG ATG GAC
TCA CCA GGT-3󸀠 and reverse 5󸀠-CCT CTA CAT GGC
CCTGTC TT-3󸀠. Genomic DNA (100 ng) was amplified with
0.5U of Taq Platinum DNA polymerase (Invitrogen, Sa˜o
Paulo, Brazil), 1.5mM MgCl2, 0.2𝜇M of each dNTP, and
0.6 pmol of each primer. Polymerase chain reactions were
run for 35 cycles: 5min at 94∘C, 30 s at 57∘C, and 1min at
72∘C, followed by a final extension at 72∘C for 5min. These
oligonucleotides generated a 251 bp fragment visualized on a
2% agarose gel stained with 2.5%GelRed (Biotium, Hayward,
USA). The product (10𝜇L) was digested with 0.5𝜇L of BbsI
(Fermentas, Vilnius, Lithuania) at 37∘C for 12 h, subjected to
electrophoresis in a 12.5% polyacrylamide gel after ethidium
bromide staining, resulting in 251 and 13 bp fragments for
the TT genotype; 251, 180, 71, and 13 bp fragments for the
TC genotype; and 180, 71, and 13 bp fragments for the CC
genotype [47].
The PCR and RFLP reactions for the TNFA-238G>A
position (rs361525) were standardized according to the pro-
tocols of Hedayati et al. [48]. The following oligonucleotides
were used: forward 5󸀠-ATC TGG AGG AAG CGG TAG TG-
3󸀠 and reverse 5󸀠-AGA AGA CCC CCC TCG GAA CC-
3󸀠. Briefly, amplification was performed in a final volume
of 25𝜇L containing 100 ng of DNA, 0.5U of Taq Platinum
Polymerase (Invitrogen, Sa˜o Paulo, Brazil), 1.5mM MgCl2,
0.2𝜇M of each dNTP, and 0.6 pmol of each primer. The
amplification reactions were performed under the following
conditions: initial denaturation for 5min at 94∘C; 35 cycles
of 30 s at 94∘C, 30 s at 60∘C, and 1min at 72∘C; and a final
extension of 5min at 72∘C,which generated a 153 bp fragment
that was visualized on a 2% agarose gel stained with 2.5%
GelRed (Biotium,Hayward, USA). A total of 10 𝜇L of the PCR
product was subjected to restriction enzyme digestion with
MspI (ThermoScientific) using 0.5 𝜇L of the required enzyme
at 37∘C for 15min.Thegenotypeswere identified asAA for the
156 bp fragment, GG for the 133 bp fragment, and GA for 153
and 133 bp fragments in a 2% agarose gel stained with 2.5%
GelRed (Biotium, Hayward, USA).
2.2.2. IL10 Genotyping. For the IL10 SNPs at the -592C>A
(rs1800872) and -819C>T positions (rs1800871), the reactions
were standardized in-house with the following oligonu-
cleotides: forward 5󸀠-GGG TGA GGA AAC CAAATT CEC-
3󸀠 and reverse 5󸀠-GAGGGGGTGGGCTAAATATC-3󸀠 .The
25𝜇L PCR mixture contained 100 ng of DNA, 0.5 U of Taq
Platinum Polymerase (Invitrogen, Sa˜o Paulo, Brazil), 1.5mM
MgCl2, 0.2𝜇M of each dNTP, 0.6 pmol of each primer, and
5% glycerol. The cycling conditions were as follows: 94∘C
for 5min; 35 cycles of 94∘C for 30 s, 54∘C for 30 s, and 72∘C
for 1min; and a final extension at 72∘C for 10min. These
oligonucleotides generated a 361 bp fragment. For the IL10-
819C>T SNP, the PCR products were digested overnight at
37∘C with 0.5𝜇L of RseI (Fermentas, Vilnius, Lithuania). For
the IL10-592C>ASNP, 10 𝜇L of the PCR product was digested
with 0.5𝜇L of the enzyme RsaI (Invitrogen, CA, EUA). After
digestion, the fragments generated at the -592C>A position
were 240, 77, 36, and 8 bp for the AA genotype; 317, 36, and
8 bp for the CC genotype; and 317, 240, 77, 36, and 8 bp for
the CA genotype. At the -819 position, the TT, CC, and TC
genotypes were identified with 270 and 91 bp; 217, 91, and
53 bp; and 270, 217, 91, and 53 bp bands, respectively. The 2%
agarose gel stained with 2.5% GelRed (Biotium, Hayward,
USA).
2.2.3. IFNGGenotyping. The polymorphism at the +874A>T
position in the IFNG gene (rs2430561) was identified
using allele-specific oligonucleotide-polymerase chain reac-
tion (ASO-PCR) according to Flori et al. [30], with modi-
fications. The oligonucleotides used were: IFNG (+874) CP:
5󸀠-TCA ACA CTG ATA AAG CTC AC-3󸀠, IFNG (+874) T:
5󸀠-TTC TTA CAA CAC AAA ATCAAA TCT-3󸀠, or IFNG
(+874) A: 5󸀠-TTC TTA CAA CAC AAA ATC AAA ATC-
3󸀠. These oligonucleotides resulted in a 264 bp fragment after
changing the annealing conditions from 56∘C for 40 s to 53∘C
for 1min by Flori et al. [30].
The amplified product was analyzed using electrophoresis
on a 2% agarose gel stained with 2.5% GelRed (Biotium,
Hayward, USA). The AA genotype was identified when a
264 bp fragment was observed in the electrophoresis of the
A allele tube, and the TT genotype was identified with the
presence of a 264 bp fragment for the T allele tube. For the
AT genotype, one 264 bp fragment was observed in each of
the two reaction tubes (A and T).
2.3. Determination of Ancestry. Individual ancestry estimates
were based on a panel of 48 insertion-deletion (InDel)
ancestry informative markers (AIMs) as described in Santos
et al. [49]. The ancestry data for the samples from Goiane´sia
do Para´ were previously presented in a larger subset of
samples in Cassiano et al. [46]. The AIMs were genotyped in
three multiplex reactions with 16 markers in each reaction,
and electrophoresis was performed on a capillary sequencer
(ABI3130 Genetic Analyzer, Applied Biosystems) under the
conditions described by de Seixas Santos Nastri et al. [50]. A
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Table 1: Characteristics of the study population.
Characteristic Mild vivaxmalaria (𝑛 = 90) Noninfected (𝑛 = 51) 𝑝 value
Gender, malea 74.4 56.9 0.03
Age (years)b 32.5 (23.75–43.5) 37.0 (26.0–45.0) 0.62
Genetic ancestryc
European 0.442 ± 0.130 0.449 ± 0.130 0.76
African 0.318 ± 0.120 0.295 ± 0.112 0.26
Native American 0.240 ± 0.094 0.256 ± 0.111 0.35
Previous malaria episodesb 5.0 (2.0–7.0) 2.0 (0–6.0) 0.06
Previous history of malariaa 91.1 68.6 <0.01
aPercentage.
bMedian (IQR).
cMean ± SD.
standard ladder (ABIGS LIZ-500, Applied Biosystems) was
used in each sample as a reference for the identification of
InDel markers. All of the investigated AIMs significantly
differed in frequency in populations of different geographical
origins.
The individual proportions of European, African, and
Native American ancestry were estimated in the program
Structure v2.3.4 using the Admixture Model with a 100,000
burn length and 100,000 iterations after burning; the allele
frequencies were independently modeled [51]. For the ances-
try estimates, the data obtained in the investigated sample
were plotted against the parental population data that formed
the Brazilian population, which included Amerindian (246),
Western European (290), and Sub-Saharan African (201)
individuals.
2.4. Statistical Analysis. All statistical analyses were per-
formed using R software. The allele, genotype, and haplo-
type frequencies and deviations from the Hardy-Weinberg
equilibrium were estimated using the SNPassoc package [52].
Differences in the ancestry proportions between genotypes
were determined using fitted logistic regression models for
age, gender, and infection status. A similar analysis was per-
formed to evaluate differences in ancestry proportions among
the different haplotypes using the haplo.glm function [53].
Binary logistic regression was used to graphically explore
the associations between the polymorphisms and ancestry
proportions using the multinom package [54]. Differences in
the genotype and haplotype frequencies between the infected
and noninfected individuals were tested using the SNPassoc
package with adjustment for the covariates age, gender, and
ancestry. In all multivariate analyses, the SNPs were included
following different genetic models (codominant, recessive,
dominant, and additive). 𝑝 values < 0.05 were considered
significant.
3. Results
3.1. Epidemiological Characteristics of the Study Participants.
The demographic data of the subjects included in the study
are listed in Table 1. Of the 141 participants, 90 (63.8%)
had mild malaria, and 51 (36.2%) individuals were not
infected at the time of collection. The proportion of men was
higher in the group with malaria (74.4%) than in group of
noninfected individuals (56.9%) (𝑝 = 0.03). Additionally, the
proportion of individuals that reported previous episodes of
clinical malaria was higher in the group of malaria-infected
individuals (91.1% versus 68.6%, 𝑝 < 0.01). Age, number of
previousmalaria episodes, and proportion of genetic ancestry
(European, African, and Native American) were similar
between the two groups. The ancestry data were previously
presented in a larger cohort by Cassiano et al. [46], who
showed that the main contribution was European (44.2%),
followed by African (31.8%) and Amerindian (24.0%) con-
tributions. There were no differences in the proportions of
African, European, and Native American ancestry by gender
(𝑝 = 0.99, 0.65, and 0.48, respectively, Mann-Whitney 𝑈-
test).
3.2. Genotype andHaplotypeDistributions. Thegenotype and
allele distributions of the studied SNPs are shown in Table 2.
The IFNG+874A>T SNPwas successfully genotyped in 92.2%
of the samples. When the allele and genotype frequencies
of the six SNPs were compared between malaria-infected
and noninfected individuals, no significant association was
observed. All SNPs were at Hardy-Weinberg equilibrium in
both groups (all 𝑝 values > 0.05) (Table 2). We conducted
the tests following the additive, dominant, recessive, and
heterozygous models, and the lowest 𝑝 values are shown in
Supplementary Table 1 (in Supplementary Material available
online at http://dx.doi.org/10.1155/2016/5168363). Although
the highest AA genotype frequency was observed for the
IFNG+874A>T SNP in the group ofmalaria-infected individ-
uals, this difference did not reach the significance level (OR =
1.87, 95% CI: 0.91–3.82, 𝑝 = 0.08).
Haplotype analyses were performed for the three SNPs
in the TNFA gene and for the two SNPs in the IL10 gene.
Four haplotypes in the TNFA gene were responsible for more
than 98% of all potential combinations. The TNFA-1031T>C
SNP was in moderate linkage disequilibrium with the TNFA-
308G>A and -238G>A SNPs (𝐷󸀠 = 0.70 and 0.67, resp.),
whereas the TNFA-308G>A and -238G>A SNPs exhibited a
𝐷󸀠 of 0.85. For the IL10 gene, strong linkage disequilibrium
occurred between the -819C>T and -592C>ASNPs and three
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Table 2: Distribution of the genotypes between vivaxmalaria-infected and noninfected individuals.
Gene SNP Genotype Malaria Noninfected p value
𝑛 (%) MAF HWE 𝑛 (%) MAF HWE
IFNG +874A>T
AA 39 (48.7)
0.30 0.91
17 (34.0)
0.37 0.08 0.22AT 34 (42.5) 29 (58.0)
TT 7 (8.8) 4 (8.0)
TNFA -1031T>C
TT 51 (56.7)
0.28 0.11
24 (47.1)
0.28 0.14 0.53TC 37 (41.1) 25 (49.0)
CC 2 (2.2) 2 (3.9)
TNFA -308G>A
GG 69 (76.7)
0.12 0.21
35 (68.7)
0.18 0.69 0.14GA 21 (23.3) 14 (27.4)
AA 0 2 (3.9)
TNFA -238G>A
GG 80 (88.9)
0.06 0.22
46 (90.2)
0.05 0.71 0.70GA 9 (10.0) 5 (9.8)
AA 1 (1.1) 0
IL10 -819C>T
CC 39 (43.3)
0.34 0.87
19 (37.2)
0.35 0.15 0.55CT 41 (45.6) 28 (54.9)
TT 10 (11.1) 4 (7.8)
IL10 -592C>A
CC 41 (45.6)
0.29 0.05
20 (39.2)
0.34 0.21 0.62CA 45 (50.0) 27 (52.9)
AA 4 (4.4) 4 (7.8)
MAF: minor allele frequency; HWE: Hardy-Weinberg equilibrium.
𝑝 values were calculated from a chi-squared test.
Table 3: Haplotype frequencies in the TNF and IL10 genes in vivax malaria-infected and noninfected individuals.
Haplotype Malariainfected Noninfected OR (95% CI) 𝑝 value
𝑇𝑁𝐹𝐴−1031/−308/−238
T/G/G 0.632 0.555 Reference 0.11
C/G/G 0.195 0.220 0.63 (0.30–1.31) 0.45
T/A/G 0.113 0.161 0.48 (0.20–1.13) 0.17
C/G/A 0.037 0.049 0.62 (0.15–2.35) 0.75
𝐼𝐿10−819/−592
C/C 0.642 0.647 Reference 0.94
T/A 0.291 0.343 0.80 (0.44–1.44) 0.33
T/C 0.054 0.009 7.19 (0.89–57.7) 0.06
Odds ratios (OR), 95% confidence interval (CI).
haplotypes were observed. The comparison of the haplotype
frequencies between the malaria-infected and noninfected
individuals is shown in Table 3.
3.3. Association between Polymorphisms and Genetic Ancestry.
The individual proportions of the African, European, and
Native American genetic ancestries were analyzed as con-
tinuous variables. In the present study, no differences were
observed in the mean proportion of any ancestry among
the different genotypes and haplotypes analyzed (Table 4
and Supplementary Table 2). Figure 1 shows the graphical
representation of the binary logistic regression model used
to evaluate the frequency of individuals carrying the mutant
allele of all analyzed SNPs in relation to the individual
genetic ancestry proportions. The frequency of individuals
carrying the TNFA-308A allele progressively decreased with
the increasing proportion of European ancestry (𝑝 = 0.03).
However, when the Bonferroni correction for multiple tests
was used, this association was no longer significant (𝑝 =
0.18). No other association was observed.
4. Discussion
Previous studies reported different allele frequencies in
cytokine genes among different ethnicities [18, 55–57]. Due
to these studies and the participation of these proteins in
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Figure 1: Binary logistic regression model used to evaluate the frequency of individuals carrying the mutant allele of all analyzed SNPs
relative to the individual proportions of genetic ancestry.The shading around the lines represents the 95% confidence interval.The graph was
constructed using the ggplot2 package in the R program.
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numerous processes related to the pathogenesis of various
diseases, we evaluated the frequencies of polymorphisms
in the TNFA, IFNG, and IL10 genes in a highly admixed
Brazilian population and related their distributions to the
proportions of genetic ancestry using AIMs. We selected a
population from northern Brazil where there was a higher
contribution of Native American ancestry due to the lack
of data in studies of this nature involving indigenous popu-
lations [58]. Because these cytokines play a key role in the
modulation of the immune response inmalaria, we evaluated
whether these polymorphisms were related to protection
against vivax malaria. However, this study did not provide
evidence of such associations.
The -308G>A SNP (rs1800629) is located in the promoter
region of the gene, and the presence of the 𝐴 allele forms a
binding site for the AP1 transcription factor that has been
associated with increases in TNF-𝛼 production [18]. The
frequency distribution of the 𝐴 allele observed in our study
(13.83%) was similar to that observed in previous studies
in the Brazilian population (12–16%) [59–61]. According to
data from the 1000 Genomes project, the frequency of the
𝐴 allele is similar between Europeans (13%) and Africans
(12%).This finding was in agreement with our results because
no differences were observed in the frequencies of this allele
according to the proportions of genetic ancestry. Contradic-
tory results were observed for malaria, with the TNFA-308A
allele associated with higher susceptibility/severity [62–64],
without alterations [39] or with resistance to P. falciparum
malaria [65]. Regarding vivax malaria, which was the focus
of the present study, our results were in agreement with other
studies, including those in the Brazilian Amazon that did not
observe any associations between the TNFA-308G>A SNP
and susceptibility or clinical manifestations due to P. vivax
infection [10, 19, 66].
The -238G>A SNP (rs361525) does not have a clearly
established function but seems to affect the circulating
cytokine levels because it is located on a repressor site in
the TNFA gene [16]. The 5.38% frequency of the A allele
(-238) in our results was similar to the data for Europeans
and Africans, which ranged from 4 to 6% [67].The frequency
of the presence of the A allele at the -238 and -376 positions
is low worldwide. In the Brazilian Amazon, previous indices
ranged from 5 to 7% [19, 68], and no associations were
described with vivax malaria in Para´ [19]. In contrast, the
GA genotype was associated with psoriasis in southeastern
Brazil [69], and the A allele was associated with a decrease in
falciparummalaria parasitemia in Burkina Faso [30], cerebral
malaria in Kenya [70], and malarial anemia [62]. This SNP
was associated with increased susceptibility to vivax malaria
in the Amazon region only when evaluated in the TATGG
haplotype (-1031/-863/-857/-308/-238) [19].
The 24.82% frequency of the C allele at the -1031 position
(rs1799964)of the TNFA gene is similar to data from the 1000
Genomes project (15% and 21% for Africans and Europeans,
resp.) and in other Brazilian population (27.9%) [68]. In
malaria, this SNP was associated with cytokine levels and
clinical symptoms but not with susceptibility in India [27].
The C allele is associated with a twofold higher chance of
cerebral malaria caused by P. falciparum [71] in Thailand. In
Africa, the CC genotype is associated with repeated malaria
episodes by P. falciparum [47, 65] and the T allele is associated
with high parasitemia [30]. In Brazil, the CC genotype is
associated with protection against leprosy but not malaria
vivax [68].
One hypothesis for the lack of association of the evaluated
SNPs is that malaria can occur due to possible linkage
disequilibrium of the SNPs in TNFA with the human
leukocyte antigens (HLAs), which can cause nonfunctional
mutations [65, 66]. The A allele (-308) is described as
having a strong linkage disequilibrium with HLA-Bw53 and
DRB1∗1302-DQB1∗0501, whereas the A allele at the -238
position of the TNFA gene appears to be linked to HLA-B53
but with different immune characteristics [62].The haplotype
frequencies in cytokine genes can vary extensively among
different ethnic groups most likely due to selective pressure
on the human genome and thus affect the susceptibility and
clinical outcomes of diseases such as malaria [36]. This effect
might have affected our results due to the admixture observed
in the Brazilian population.
The gene sequence of this cytokine is highly conserved,
with few polymorphisms. The SNP at the -183G>T position
is related to increased transcription activity [26], whereas
+874A>T is located in a region where the number of repli-
cates can modulate the expression of messenger RNA and the
production of cytokines [21, 72]. The T allele is associated
with a high number of replicate copies and activates the
transcription site for the NF-𝜅B pathway, which correlates
with high cytokine expression [73, 74]. The AA, TA, and TT
genotypes are associated with low, intermediate, and high
production of IFN-𝛾, respectively [21, 75].
The highest frequency of the A allele (IFNG+874) is
described in individuals with European ancestry and is
46% (http://hapmap.ncbi.nlm.nih.gov/). Indeed, the eval-
uated population in the present study had a European
contribution of almost 50% [46], and the frequency of
this allele was detected in 67.3% of the evaluated sample.
However, no association was detected with any ancestry or
with malaria. Studies conducted in the United States with
African-American and Caucasian populations found higher
frequencies of 66% and 37% [76] and 48% and 25% [77],
respectively. Our data showing the higher frequency of the
mutant A allele are in agreement with studies in the Brazilian
Amazon that found frequencies of 70.13% [21] and 73% [17]
but all lacked an association with malaria caused by P. vivax
or P. falciparum. Few studies have described an association
between this SNP with malaria; however, its association with
dermatitis was observed in India [78]. Importantly, higher
levels of this cytokine allow a better immune response against
obligate intracellular pathogens; thus, low frequencies of A
allele may be associated with susceptibility to the disease.
The IL10 gene has more than 27 polymorphic sites
associated with SNPs that result in the differential production
and expression of the cytokine [17, 36, 79], autoimmune and
inflammatory diseases [80], bacterial [81] and viral infections
[75], and human malaria [21]. The allele distributions for T
(-819) and A (-592) in our results were 35.4% and 31.2%,
respectively; these distributions were higher in Europeans
than in Africans but lacked significant associations. These
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data disagree with those from the 1000 Genomes project
[67], which report a higher frequency of the mutant alleles
in Africans. Lokossou et al. [82] reported higher frequencies
(41.53% and 41.31% for the T and A alleles in SNPs -819
and -592, resp.) for falciparum malaria in Benin. The allele
and genotype distributions of SNPs in IL10 are described
as variables according to ethnic group [21, 36] and the A
(-592), T (-819), and A (-1082) alleles are more frequent
among African-Americans [82, 83]. Another study byMoraes
et al. [80] did not find significant differences in the frequen-
cies of genotypes, alleles, and haplotypes of five IL10 SNPs
(–3575, –2849, 2763, –1082, and –819) between the Brazilian
and Dutch populations. However, studies of indigenous
populations are scarce. In Brazil, a study of indigenous people
from the Terena tribe of the state of Mato Grosso do Sul
showed that the frequency of mutant alleles (-819T and
-592A) was significantly higher than in individuals residing
in Rio de Janeiro [84]. By contrast, we obtained the lowest
rates for this ancestry, and no association was observed.
The CC genotypes for the two SNPS were associated with
a decrease in IL-10 levels and low parasitemia in northern
Brazil [17], which agreed with our data indicating no signif-
icant association with susceptibility to malaria. Two studies
in Para´ state, Brazil, also described no haplotype associations
of the IL10 gene with malaria [19, 21] and falciparummalaria
in Africa [36]. In Piracicaba, southeastern Brazil, these SNPs
were associated with chronic periodontitis in Caucasians
[85]. Future analyses of parasitemia and cytokine indices
may identify associations between the SNPs in the evaluated
sample. One hypothesis for the lack of association is that
the patients involved in the present study did not have
malarial complications caused by P. vivax. Additionally, the
transmission profile of the malaria of the area investigated
could have had an effect, and the epidemiology was different
from that observed inAfrica. Another explanationmay be the
low frequency of some genotypes in the present study. Thus,
the sample size may have been too small to find any possible
association. This finding warrants further investigation.
5. Conclusion
The evaluation of ancestry informative markers (AIMs)
allows estimations of admixtures at the individual level and
avoids possible confounding factors due to ethnicity, such as
in the trihybrid population sample evaluated in this study.
The polymorphisms in the TNFA, IFNG, and IL10 genes
investigated in this study did not significantly differ according
to ancestry and were not associated with risk or protection
against vivaxmalaria. However, there was a decreasing trend
in the frequency of the A allele with increasing proportion
of European ancestry. In Brazil, this is the first study to
evaluate the distribution of these genes according to ancestry.
The results support the application of ancestry informative
markers in future studies.
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